- All sections
- C - Chemistrymetallurgy
- C12Q - Measuring or testing processes involving enzymes, nucleic acids or microorganismscompositions or test papers thereforprocesses of preparing such compositionscondition-responsive control in microbiological or enzymological processes
- C12Q 1/6848 - Nucleic acid amplification reactions characterised by the means for preventing contamination or increasing the specificity or sensitivity of an amplification reaction
Patent holdings for IPC class C12Q 1/6848
Total number of patents in this class: 874
10-year publication summary
|
36
|
45
|
81
|
120
|
89
|
119
|
135
|
81
|
101
|
28
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Natera, Inc. | 311 |
53 |
| Bio-Rad Laboratories, Inc. | 1606 |
31 |
| Life Technologies Corporation | 3262 |
23 |
| Gen-Probe Incorporated | 1000 |
21 |
| Illumina, Inc. | 3254 |
21 |
| President and Fellows of Harvard College | 5932 |
12 |
| F. Hoffmann-La Roche AG | 7908 |
11 |
| Roche Molecular Systems, Inc. | 920 |
11 |
| Roche Sequencing Solutions, Inc. | 632 |
11 |
| Noul Co., Ltd. | 48 |
11 |
| Illumina Cambridge Limited | 681 |
9 |
| Integrated DNA Technologies, Inc. | 272 |
9 |
| New England BioLabs, Inc. | 485 |
9 |
| Lumiradx UK Ltd | 63 |
8 |
| Qiagen GmbH | 895 |
8 |
| Roche Diagnostics GmbH | 2683 |
7 |
| Pacific Biosciences of California, Inc. | 754 |
7 |
| Seegene, Inc. | 381 |
7 |
| Samplix ApS | 30 |
7 |
| Qiagen Sciences, LLC | 186 |
6 |
| Other owners | 592 |